GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5525 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP3, HSD17B2, HSP90AB1, IGF1R, MMP2, MMP9, NR3C1, POLB, PPARA, PPARG, SRC, TRPV1, TYR |
11.2809 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MMP2, NR3C1, POLB, PPARA, PPARG, SRC, TRPV1, TYR |
11.0162 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9347 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PPARA, PPARG, TBXAS1, TRPV1 |
10.3438 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.56844 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MMP2, MMP9, NR3C1, POLB, PPARA, PPARG, SRC, TRPV1, TYR |
9.39876 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, SRC, TRPV1, TYR |
9.09817 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, MIF, PIM1, PPARA, PPARG, TBXAS1, TYR, XDH |
8.70947 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MCL1, MET, MIF, POLA1, POLB, PPARA, PPARG, SRC, TRPV1, XDH |
8.70947 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TBXAS1, TRPV1, TYR, XDH |
8.25975 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, NR3C1, PPARG, SRC, TYR |
8.25975 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
7.5918 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP9, PIM1, PPARG, PTPN1, SRC, TRPV1, XDH |
7.49994 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD11B1, HSD17B1, HSD17B2 |
7.24642 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARA, PPARG, SRC, TRPV1 |
6.98884 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, MCL1, MET, POLA1, POLB, PPARG, SRC, TRPV1 |
6.95401 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MIF, MMP9, PIM1, PPARG, PTPN1, SRC, TRPV1, XDH |
6.90598 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, TRPV1 |
6.82052 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, SRC, TRPV1 |
6.68835 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TBXAS1, TYR, XDH |
6.44883 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, FABP3, HSP90AB1, KDR, NR3C1, POLB, PPARG, SRC, TRPV1 |
6.42268 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MIF, MMP12, MMP2, MMP9, NR3C1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TRPV1, TYR |
6.42268 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARA, PPARG, SRC |
6.2826 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, FABP3, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
6.2826 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, FLT3, HCAR2, HSP90AB1, KDR, MCL1, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
6.2433 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, NR3C1, PPARA, PPARG, SRC, TRPV1 |
6.2433 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, FLT3, HCAR2, HSP90AB1, KDR, MCL1, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
6.21835 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MCL1, MIF, MMP2, MMP9, NR3C1, POLA1, POLB, PPARG, PTPN1, SRC, TRPV1 |
6.1536 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, HSP90AA1, KDR, POLB, SRC |
6.10225 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, TBXAS1 |
6.01322 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, POLB, PPARA, PPARG, SRC, TYR |
5.79011 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, TBXAS1 |
5.79011 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC |
5.71842 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, SRC, TRPV1 |
5.65947 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PGR, PIM1, PPARG, SRC, XDH |
5.64862 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, NR3C1, PPARG, SRC, TRPV1 |
5.64862 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, TRPV1 |
5.57322 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSP90AB1, KDR, MCL1, MET, MIF, MMP2, MMP9, PGR, PIM1, POLB, PPARA, PPARG, SRC, TYR |
5.53447 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP9, PIM1, PTPN1, SRC |
5.53396 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PPARG, TBXAS1 |
5.53326 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARA, PPARG, SRC |
5.52026 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.43561 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, PIM1, PPARA, PPARG, SRC |
5.35767 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
5.35497 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.18301 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, PPARG, PTPN1, SRC, XDH |
5.04325 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, MET, MIF, PPARA, PPARG, TBXAS1 |
4.97629 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, MCL1, MMP9, PGR, PIM1, POLB, PPARA, PPARG, SRC, TYR |
4.96356 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
4.95127 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, PPARG, PTPN1, SRC, XDH |
4.95127 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HSP90AB1, IGF1R, KDR, MCL1, MIF, MMP9, PIM1, PTPN1, SRC |
4.92184 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SRC, TRPV1, TYR |
4.7765 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, HSP90AA1, HSP90AB1, MMP2, POLB, PPARA, PPARG, SRC, TRPV1, TYR |
4.7677 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
4.67705 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, PPARG, TBXAS1, TYR, XDH |
4.67705 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, TBXAS1 |
4.67705 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.609 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARA, PPARG |
4.58593 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CNR1, DRD1, HCAR2, KDR, MIF, SRC, TRPV1 |
4.57409 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CNR1, CNR2, CYP19A1, ESR1, FABP4, HSP90AA1, HSP90AB1, IGF1R, MCL1, MET, MIF, MMP12, MMP2, PPARA, PPARG, PTPN1, SRC, XDH |
4.5564 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.55013 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, HCAR2, HSP90AB1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARG, PTPN1, SRC, TRPV1 |
4.49988 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, BCL2, CNR1, CNR2, CYP19A1, DRD1, ESR1, ESR2, IGF1R, MCL1, MET, MIF, MMP12, MMP9, PPARA, PPARG, PTPN1, SRC, XDH |
4.45709 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLB, PPARA, PPARG, PTPN1, SRC, TRPV1 |
4.45709 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SRC, TRPV1, TYR |
4.41926 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.39375 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, HSD17B2, HSP90AB1, MMP2, MMP9, PGR, PPARG, SRC |
4.39375 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD11B1, HSD17B1, HSD17B2 |
4.29382 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, ESR1, ESR2, FABP4, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
4.18442 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TBXAS1, TRPV1, TYR, XDH |
4.17646 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
4.11461 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, NR3C1, PPARG, SRC, TRPV1 |
4.10345 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, CNR2, DRD1, ESR1, ESR2, IGF1R, MCL1, MET, MIF, MMP12, MMP9, PPARG, PTPN1, SRC, XDH |
4.07149 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, CNR2, DRD1, ESR1, ESR2, IGF1R, MCL1, MET, MIF, MMP12, MMP9, PPARG, PTPN1, SRC, XDH |
4.05594 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, MIF, PIM1, POLA1, SRC, TYR |
4.00403 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSP90AB1, PPARG, SRC |
3.99478 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, IGF1R, KDR, MET, MIF, MMP9, PPARG, SRC |
3.99478 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC |
3.9671 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARA, PPARG |
3.87472 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, SRC |
3.87472 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, HSP90AB1, KDR, NR3C1, SRC, TRPV1 |
3.87082 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, HSD17B2, IGF1R, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, TYR |
3.85168 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, KDR, SRC, TRPV1 |
3.84635 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
3.79845 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HSP90AB1, KDR, MCL1, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
3.75585 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PPARG, TBXAS1 |
3.75108 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, FABP4, FLT3, HSP90AA1, HSP90AB1, KDR, MCL1, MET, MIF, MMP12, MMP2, MMP9, PTPN1, SRC, XDH |
3.75108 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, IGF1R, KDR, MET, MIF, MMP9, PPARG, SRC |
3.72304 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MCL1, MIF, MMP9, PTPN1, SRC |
3.6966 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, FABP3, FABP4, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
3.69478 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
3.69478 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD1, HCAR2, HSP90AB1, MIF, MMP12, PPARG, SRC, TRPV1 |
3.66895 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, HSD17B2, HSP90AB1, PGR, PPARG, SRC |
3.66023 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, FABP3, FABP4, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
3.63911 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TBXAS1, TRPV1, TYR, XDH |
3.63691 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, HSP90AA1, HSP90AB1, MCL1, MIF, MMP2, MMP9, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TRPV1 |
3.63553 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
3.62528 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, FLT3, KDR, MCL1, MET, MIF, PTPN1, SRC, XDH |
3.61695 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.61302 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.61302 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.61302 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
3.61263 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, DRD1, ESR1, ESR2, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
3.41557 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1 |
3.4128 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, ESR1, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MIF, MMP9, PPARG, PTPN1, SRC, XDH |
3.40281 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.40038 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, IGF1R, KDR, MET, MIF, MMP9, PPARG, SRC |
3.38801 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, IGF1R, KDR, MET, MIF, MMP9, PPARG, SRC |
3.37427 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA, PPARG |
3.36382 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
3.31242 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, PPARG, SRC |
3.30223 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MCL1, MET, MIF, MMP9, PTPN1, SRC, XDH |
3.28938 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PPARG, SRC |
3.28938 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, ESR1, FABP4, KDR, MET, MIF, MMP12, PPARA, PPARG |
3.28938 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, HSP90AB1, MMP12, MMP2, PPARA, PPARG, PTPN1, SRC |
3.26884 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.26492 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP2, MMP9, PPARA, PPARG, PTPN1, SRC, XDH |
3.26492 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSP90AA1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.25248 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, HCAR2, HSP90AB1, MCL1, MET, PPARA |
3.21845 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.20764 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
3.18475 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, ESR1, HCAR2, HSP90AA1, HSP90AB1, MIF, MMP12, MMP2, PPARG, PTPN1, SRC |
3.18309 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, HCAR2, HSP90AB1, MIF, MMP12, MMP9, PPARA, PPARG, PTPN1, SRC, TRPV1 |
3.18309 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DRD1, ESR1, FLT3, IGF1R, MMP2, NR3C1, PPARG, SRC, TRPV1 |
3.17933 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.17549 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1631 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, ESR1, FABP3, FABP4, MET, PPARG, TRPV1 |
3.15855 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PPARG, SRC |
3.13474 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.08276 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP3, FLT3, HSP90AB1, KDR, MIF, MMP9, PTPN1, SRC, XDH |
3.08276 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP3, FLT3, HSP90AB1, KDR, MIF, MMP9, PTPN1, SRC, XDH |
3.08276 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.04417 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PGR, PPARA, PPARG, SRC |
3.01364 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TBXAS1, TRPV1, TYR, XDH |
2.99172 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, POLB, PPARA, PPARG, SRC |
2.94661 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC, XDH |
2.94534 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PPARG, TBXAS1, TYR |
2.93242 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MCL1, MIF, MMP9, PTPN1, SRC |
2.90581 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, PPARG, SRC |
2.89934 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.89883 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, DRD1 |
2.86183 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, DRD1 |
2.86183 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
2.84891 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CNR1, CNR2, DRD1, KDR, SRC, TRPV1 |
2.84891 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.84891 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, ESR1, ESR2, FABP3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, PPARG, SRC, TRPV1 |
2.83511 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, NR3C1, SRC |
2.82902 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, HSP90AB1, NR3C1, PPARG |
2.81319 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MCL1, MET, MIF, MMP9, PTPN1, SRC, XDH |
2.79565 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.76348 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, TYR |
2.75269 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.74773 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, HCAR2, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARG, SRC, TRPV1 |
2.63896 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MCL1, MIF, MMP9, PTPN1, SRC |
2.63392 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.62202 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, PPARG, SRC, TRPV1, TYR |
2.62202 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, MCL1, SRC |
2.60034 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.60034 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CNR1, CYP1A1, DRD1, ESR1, PGR, SRC |
2.59101 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, FLT3, HSP90AB1, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.55094 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PPARG, TBXAS1, TYR |
2.54348 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.53759 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, CNR1, CSNK2A1, ESR1, ESR2, FABP4, HSP90AB1, IGF1R, MCL1, MET, MIF, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
2.53574 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, MET, MIF, MMP9, PPARG, PTPN1, SRC, XDH |
2.51839 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.49723 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, HSP90AA1, HSP90AB1, TRPV1, XDH |
2.49649 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PPARG, TBXAS1, TYR |
2.47569 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, MMP12, PPARA, PPARG |
2.47186 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, PPARA, PPARG, SRC, TRPV1 |
2.47052 |
[BP] GO:0021700 |
developmental maturation
|
APP, AXL, CDC25B, MMP2, PGR, PPARG |
2.46168 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.45064 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.441 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.441 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.43663 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.43663 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, ESR1, ESR2, FABP3, HSP90AA1, HSP90AB1, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, PPARG, SRC, TRPV1 |
2.4315 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.43092 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, POLB, PTPN1, SRC, XDH |
2.42062 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.41172 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.40145 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.40145 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, FLT3, HSP90AB1, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.40063 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF, PPARG |
2.38454 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP2, MMP9, PTPN1, SRC, TRPV1 |
2.37351 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, FABP3, PPARA, PPARG, TRPV1 |
2.37023 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.34697 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.34057 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, FABP3, HSP90AA1, MCL1, MMP12, PPARA, PPARG, TRPV1 |
2.30573 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, HSP90AB1 |
2.30383 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MIF, PPARG, PTPN1, SRC |
2.3005 |
[BP] GO:0055093 |
response to hyperoxia
|
CYP1A1, POLB, PPARG |
2.3005 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, HCAR2, MCL1, MMP9, PPARG, SRC, TRPV1, XDH |
2.29302 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, PPARA, PPARG |
2.29293 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CNR1, ESR1, IGF1R, KDR, MET, MMP1, MMP9, PPARG, SRC |
2.28485 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.28485 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, MIF, PPARA, PPARG |
2.26695 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, HCAR2, MCL1, MMP9, PPARG, SRC, TRPV1, XDH |
2.26628 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF, PPARG |
2.2607 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, HCAR2, MIF, MMP12, SRC, TRPV1 |
2.25572 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.2556 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.2556 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, MET, TRPV1 |
2.25541 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.25214 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, PPARG, TRPV1, TYR |
2.25214 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, ESR1, ESR2, IGF1R, MCL1, MET, MIF, MMP12, MMP9, PPARG, PTPN1, SRC, XDH |
2.25214 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, PIM1, PPARG |
2.22385 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, PPARA, PPARG |
2.22385 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1 |
2.21544 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, MCL1, SRC |
2.21298 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21298 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, POLB, PTPN1, SRC, XDH |
2.21124 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.21124 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.21124 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21124 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PPARG, SRC |
2.19485 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, PPARG, SRC, TRPV1 |
2.18704 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1 |
2.18704 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.18704 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.18375 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.17846 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17846 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, APP, AR, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, FABP3, HSP90AA1, HSP90AB1, MCL1, MIF, MMP12, MMP9, PPARA, PPARG, SRC, TRPV1, XDH |
2.17846 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.17152 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
2.17152 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.16278 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF, PPARG |
2.16221 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.16221 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, ESR1, ESR2, HSP90AA1, HSP90AB1, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC |
2.15805 |
[BP] GO:0048469 |
cell maturation
|
APP, AXL, CDC25B, PGR, PPARG |
2.13816 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, PPARG, SRC, TRPV1, TYR |
2.13604 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CNR1, CNR2, CYP19A1, MIF, MMP12, PPARG |
2.13015 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CHRM2, CNR1, CYP1B1, ESR1, HCAR2, HSP90AB1, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARG, SRC, TRPV1, XDH |
2.08694 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, PPARG, PTPN1, SRC, XDH |
2.08378 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.07007 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, HCAR2, MCL1, MMP9, PPARG, SRC, TRPV1, XDH |
2.06698 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.06433 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF, PPARG |
2.06007 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP1A1, DRD1, ESR1, FABP4, FLT3, FUT7, KDR, MCL1, MET, MIF, MMP2, MMP9, PGR, PPARG, SRC |
2.05771 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.04552 |
[BP] GO:0010891 |
None
|
PPARA, PPARG |
2.04552 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, FLT3, PPARG |
2.0437 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, BCL2, CDC25B, DRD1, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.04252 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, HSP90AA1, KDR, SRC |
2.04001 |
[BP] GO:0036296 |
response to increased oxygen levels
|
CYP1A1, POLB, PPARG |
2.02252 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, HCAR2, MIF |
2.02252 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.02252 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.02236 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CNR1, HCAR2, HSP90AB1, MIF, MMP12, PTPN1, SRC |
2.02071 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, FLT3, FUT7, HSP90AA1, HSP90AB1, MIF, MMP9, SRC, TRPV1 |
2.01288 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, PPARG, SRC, TRPV1 |
2.01151 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9 |
2.00893 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.00636 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, PPARA, PPARG, PTPN1, SRC, TRPV1, XDH |
2.00504 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MCL1, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, PPARG, PTPN1, SRC, TBXAS1, TRPV1, TYR, XDH |
3.87082 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP2, NR3C2, PGR, PIM1, PTPN1, SRC, TBXAS1, TRPV1, TYR |
2.87376 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, HSP90AA1, HSP90AB1, SRC, TRPV1 |
2.74884 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, FLT3, HSD11B1, HSD17B2, NR3C2, PTPN1, TBXAS1 |
2.40512 |
[CC] GO:1904813 |
None
|
ALOX5, HSP90AA1, HSP90AB1, MIF, MMP9 |
2.18463 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, HSD11B1, HSD17B2, NR3C2, TBXAS1 |
2.14881 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, NR3C2, PTPN1, SRC, TBXAS1, TRPV1, TYR |
2.10066 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, TBXAS1, TYR, XDH |
19.6544 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.2584 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
11.0515 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, SRC, TBXAS1, TRPV1, TYR, XDH |
11.0515 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9347 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PPARG, PTPN1 |
10.137 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, ESR1, ESR2, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, TBXAS1, TRPV1, TYR, XDH |
8.46555 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARA, PPARG |
7.47982 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PPARG, PTPN1, TBXAS1, TRPV1, TYR, XDH |
7.45842 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PTPN1, SRC, TBXAS1, TYR, XDH |
7.41114 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
7.36992 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.60845 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
6.07596 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, XDH |
5.63502 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, CNR1, CNR2, DRD1, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, TRPV1 |
5.54726 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARA, PPARG, SRC, TRPV1 |
5.29565 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.24855 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, TBXAS1 |
5.21169 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, PGR, PPARA, PPARG |
5.16734 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, PGR, PPARA, PPARG |
5.16734 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, HSD17B1, NR3C1, NR3C2, PGR |
5.11995 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, TBXAS1 |
4.99492 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
4.97974 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, CNR1, CNR2, DRD1, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, TRPV1 |
4.78351 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
4.67705 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, CNR1, CNR2, DRD1, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, TRPV1 |
4.59185 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, CHRM2, CNR1, CNR2, DRD1, ESR1, ESR2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, TRPV1 |
4.17279 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.95192 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MIF, MMP9, PGR, PPARG, TRPV1, TYR, XDH |
3.90793 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, PPARG, TRPV1 |
3.87463 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, POLA1, SRC, TBXAS1, XDH |
3.72304 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.61302 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.37427 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.26884 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, ESR1, ESR2, HSP90AA1, HSP90AB1, MET, MIF, NR3C1, PGR, POLA1, POLB, PPARA, PPARG, PTPN1, SRC |
3.24225 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.08276 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.96133 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, XDH |
2.94661 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.94534 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.83896 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.83896 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1 |
2.82487 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.62202 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSP90AB1, KDR, NR3C1 |
2.441 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.43663 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.2448 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.21124 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.10283 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, FLT3, HCAR2, IGF1R, KDR, MET, PPARG, TRPV1 |
2.06007 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, FLT3, HCAR2, IGF1R, KDR, MET, PPARG, TRPV1 |
2.06007 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.05709 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.05709 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04552 |
[MF] GO:0051434 |
BH3 domain binding
|
BCL2, MCL1 |
2.04552 |